These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21209377)

  • 21. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS.
    Yaouanq J; Semana G; Eichenbaum S; Quelvennec E; Roth MP; Clanet M; Edan G; Clerget-Darpoux F
    Science; 1997 May; 276(5313):664-5. PubMed ID: 9157540
    [No Abstract]   [Full Text] [Related]  

  • 23. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study.
    Laaksonen M; Pastinen T; Sjöroos M; Kuokkanen S; Ruutiainen J; Sumelahti ML; Reijonen H; Salonen R; Wikström J; Panelius M; Partanen J; Tienari PJ; Ilonen J
    J Neuroimmunol; 2002 Jan; 122(1-2):140-5. PubMed ID: 11777553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
    ; ; Sawcer S; Hellenthal G; Pirinen M; Spencer CC; Patsopoulos NA; Moutsianas L; Dilthey A; Su Z; Freeman C; Hunt SE; Edkins S; Gray E; Booth DR; Potter SC; Goris A; Band G; Oturai AB; Strange A; Saarela J; Bellenguez C; Fontaine B; Gillman M; Hemmer B; Gwilliam R; Zipp F; Jayakumar A; Martin R; Leslie S; Hawkins S; Giannoulatou E; D'alfonso S; Blackburn H; Martinelli Boneschi F; Liddle J; Harbo HF; Perez ML; Spurkland A; Waller MJ; Mycko MP; Ricketts M; Comabella M; Hammond N; Kockum I; McCann OT; Ban M; Whittaker P; Kemppinen A; Weston P; Hawkins C; Widaa S; Zajicek J; Dronov S; Robertson N; Bumpstead SJ; Barcellos LF; Ravindrarajah R; Abraham R; Alfredsson L; Ardlie K; Aubin C; Baker A; Baker K; Baranzini SE; Bergamaschi L; Bergamaschi R; Bernstein A; Berthele A; Boggild M; Bradfield JP; Brassat D; Broadley SA; Buck D; Butzkueven H; Capra R; Carroll WM; Cavalla P; Celius EG; Cepok S; Chiavacci R; Clerget-Darpoux F; Clysters K; Comi G; Cossburn M; Cournu-Rebeix I; Cox MB; Cozen W; Cree BA; Cross AH; Cusi D; Daly MJ; Davis E; de Bakker PI; Debouverie M; D'hooghe MB; Dixon K; Dobosi R; Dubois B; Ellinghaus D; Elovaara I; Esposito F; Fontenille C; Foote S; Franke A; Galimberti D; Ghezzi A; Glessner J; Gomez R; Gout O; Graham C; Grant SF; Guerini FR; Hakonarson H; Hall P; Hamsten A; Hartung HP; Heard RN; Heath S; Hobart J; Hoshi M; Infante-Duarte C; Ingram G; Ingram W; Islam T; Jagodic M; Kabesch M; Kermode AG; Kilpatrick TJ; Kim C; Klopp N; Koivisto K; Larsson M; Lathrop M; Lechner-Scott JS; Leone MA; Leppä V; Liljedahl U; Bomfim IL; Lincoln RR; Link J; Liu J; Lorentzen AR; Lupoli S; Macciardi F; Mack T; Marriott M; Martinelli V; Mason D; McCauley JL; Mentch F; Mero IL; Mihalova T; Montalban X; Mottershead J; Myhr KM; Naldi P; Ollier W; Page A; Palotie A; Pelletier J; Piccio L; Pickersgill T; Piehl F; Pobywajlo S; Quach HL; Ramsay PP; Reunanen M; Reynolds R; Rioux JD; Rodegher M; Roesner S; Rubio JP; Rückert IM; Salvetti M; Salvi E; Santaniello A; Schaefer CA; Schreiber S; Schulze C; Scott RJ; Sellebjerg F; Selmaj KW; Sexton D; Shen L; Simms-Acuna B; Skidmore S; Sleiman PM; Smestad C; Sørensen PS; Søndergaard HB; Stankovich J; Strange RC; Sulonen AM; Sundqvist E; Syvänen AC; Taddeo F; Taylor B; Blackwell JM; Tienari P; Bramon E; Tourbah A; Brown MA; Tronczynska E; Casas JP; Tubridy N; Corvin A; Vickery J; Jankowski J; Villoslada P; Markus HS; Wang K; Mathew CG; Wason J; Palmer CN; Wichmann HE; Plomin R; Willoughby E; Rautanen A; Winkelmann J; Wittig M; Trembath RC; Yaouanq J; Viswanathan AC; Zhang H; Wood NW; Zuvich R; Deloukas P; Langford C; Duncanson A; Oksenberg JR; Pericak-Vance MA; Haines JL; Olsson T; Hillert J; Ivinson AJ; De Jager PL; Peltonen L; Stewart GJ; Hafler DA; Hauser SL; McVean G; Donnelly P; Compston A
    Nature; 2011 Aug; 476(7359):214-9. PubMed ID: 21833088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Disanto G; Magalhaes S; Handel AE; Morrison KM; Sadovnick AD; Ebers GC; Banwell B; Bar-Or A;
    Neurology; 2011 Mar; 76(9):781-6. PubMed ID: 21288988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic background of multiple sclerosis.
    Sadovnick AD
    Autoimmun Rev; 2012 Jan; 11(3):163-6. PubMed ID: 21619948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
    Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
    Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DRB1, TAP2/TAP1, and HLA-DPB1 haplotypes in Finnish juvenile idiopathic arthritis: more complexity within the MHC.
    Runstadler JA; Säilä H; Savolainen A; Leirisalo-Repo M; Aho K; Tuomilehto-Wolf E; Tuomilehto J; Seldin MF
    Genes Immun; 2004 Nov; 5(7):562-71. PubMed ID: 15343265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients.
    Bennetts BH; Teutsch SM; Buhler MM; Heard RN; Stewart GJ
    Hum Immunol; 1999 Sep; 60(9):886-93. PubMed ID: 10527398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
    Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
    Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease.
    Bilbao JR; Martín-Pagola A; Vitoria JC; Zubillaga P; Ortiz L; Castaño L
    Tissue Antigens; 2002 Jul; 60(1):71-6. PubMed ID: 12366785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.
    Gourraud PA; McElroy JP; Caillier SJ; Johnson BA; Santaniello A; Hauser SL; Oksenberg JR
    Ann Neurol; 2011 Jan; 69(1):65-74. PubMed ID: 21280076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis and the major histocompatibility complex.
    Ramagopalan SV; Knight JC; Ebers GC
    Curr Opin Neurol; 2009 Jun; 22(3):219-25. PubMed ID: 19387341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Taqman assay for high-throughput genotyping of the multiple sclerosis-associated HLA-DRB1*1501 allele.
    Goris A; Walton A; Ban M; Dubois B; Compston A; Sawcer S
    Tissue Antigens; 2008 Oct; 72(4):401-3. PubMed ID: 18647361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genome-wide scan in forty large pedigrees with multiple sclerosis.
    Willer CJ; Dyment DA; Cherny S; Ramagopalan SV; Herrera BM; Morrison KME; Sadovnick AD; Risch NJ; Ebers GC
    J Hum Genet; 2007; 52(12):955-962. PubMed ID: 18000641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.
    Bronson PG; Caillier S; Ramsay PP; McCauley JL; Zuvich RL; De Jager PL; Rioux JD; Ivinson AJ; Compston A; Hafler DA; Sawcer SJ; Pericak-Vance MA; Haines JL; ; Hauser SL; Oksenberg JR; Barcellos LF
    Hum Mol Genet; 2010 Jun; 19(11):2331-40. PubMed ID: 20211854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus.
    Lee HS; Lee AT; Criswell LA; Seldin MF; Amos CI; Carulli JP; Navarrete C; Remmers EF; Kastner DL; Plenge RM; Li W; Gregersen PK
    Mol Med; 2008; 14(5-6):293-300. PubMed ID: 18309376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.